28 April 2022 – Following the inclusion of multiple micronutrient supplements (MMS) in the World Health Organization’s (WHO) list of essential medicines (EML), HMHB published a blog on the significance of this landmark step and its implications for low and middle-income countries and vulnerable pregnant women who lack access to critical nutrition and antenatal health care services.
Iron and folic acid (IFA) supplementation has been a core component of antenatal care programs in many countries. The introduction or transition to MMS, which includes essential vitamins and minerals, in addition to IFA, can significantly improve the health and lives of mothers and babies worldwide. The registration of MMS on the WHO’s EML represents a significant step forward in creating an enabling environment for it to be delivered through health systems.
